Tumor Immunotherapy Program, Campbell Family Institute for Breast Cancer Research, Campbell Family Cancer Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, M5G 2M9, Canada; Department of Immunology, University of Toronto, Toronto, Ontario, M5S 1A8, Canada.
Tumor Immunotherapy Program, Campbell Family Institute for Breast Cancer Research, Campbell Family Cancer Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, M5G 2M9, Canada.
J Autoimmun. 2019 Aug;102:114-125. doi: 10.1016/j.jaut.2019.04.023. Epub 2019 May 8.
Recent work has delineated key differences in the antigen processing and presentation mechanisms underlying HLA-DP alleles encoding glycine at position 84 of the DPβ chain (DP). These DPs are unable to associate with the class II-associated Ii peptide (CLIP) region of the invariant chain (Ii) chaperone early in the endocytic pathway, leading to continuous presentation of endogenous antigens. However, little is known about the chaperone support involved in the loading of these endogenous antigens onto DP molecules. Here, we demonstrate the proteasome and TAP dependency of this pathway and reveal the ability of HLA class I to compete with DP for the presentation of endogenous antigens, suggesting that shared subcellular machinery may exist between the two classes of HLA. We identify physical interactions of prototypical class I-associated chaperones with numerous DP alleles, including TAP2, tapasin, ERp57, calnexin, and calreticulin, using a conventional immunoprecipitation and immunoblot approach and confirm the existence of these interactions in vivo through the use of the BioID2 proximal biotinylation system in human cells. Based on immunological assays, we then demonstrate the ability of each of these chaperones to facilitate the presentation of endogenously derived, but not exogenously derived, antigens on DP molecules. Considering previous genetic and clinical studies linking DP to disease frequency and severity in autoimmune disease, viral infections, and cancer, we suggest that the above chaperones may form the molecular basis of these observable clinical differences through facilitating the presentation of endogenously derived antigens to CD4 T cells.
最近的工作已经描绘了 HLA-DP 等位基因编码 DPβ链第 84 位甘氨酸(DP)的抗原加工和呈递机制的关键差异。这些 DP 无法与不变链(Ii)伴侣分子的 II 类相关肽(CLIP)区域在胞内途径早期结合,导致内源性抗原的持续呈递。然而,对于这些内源性抗原加载到 DP 分子上所涉及的伴侣分子支持知之甚少。在这里,我们证明了这个途径的蛋白酶体和 TAP 依赖性,并揭示了 HLA 类 I 分子与 DP 竞争内源性抗原呈递的能力,这表明这两类 HLA 之间可能存在共享的亚细胞机制。我们使用传统的免疫沉淀和免疫印迹方法,鉴定了典型的 I 类相关伴侣分子与包括 TAP2、tapasin、ERp57、钙网蛋白和钙调蛋白在内的众多 DP 等位基因的物理相互作用,并通过在人类细胞中使用 BioID2 近端生物素化系统在体内证实了这些相互作用的存在。基于免疫测定,我们随后证明了这些伴侣分子中的每一种都能够促进内源性衍生而非外源性衍生抗原在 DP 分子上的呈递。考虑到先前的遗传和临床研究将 DP 与自身免疫性疾病、病毒感染和癌症中的疾病频率和严重程度联系起来,我们认为上述伴侣分子可能通过促进内源性衍生抗原向 CD4 T 细胞的呈递,从而形成这些可观察到的临床差异的分子基础。